IM
I-Mab
IMAB·NASDAQShanghai CNFounded 2016300 employees
Micro CapbiotechPublicOncologyImmunology
Platform: Lemzoparlimab
Market Cap
$0.15B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (IMAB)
Loading IMAB stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixabrutinib | IMA-2934 | Preclinical | 1 | C5 | Bladder Ca | ||
| Miritinib | IMA-3507 | Phase 2/3 | 1 | BET | TTR AmyloidosisBCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)